Agoracom: Small Cap Investment - CV Technologies - COLD-FX® Maker Changes Company Name to Afexa Life Sciences Inc.

Welcome to the CV Technologies HUB on AGORACOM

COLD-fX remains the #1 selling cold and flu remedy in Canada

Reply New Message

Back To Forum List View

Clavis

Rank: President [?]

Points: 26378 [?]

Votes: 242 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

COLD-FX® Maker Changes Company Name to Afexa Life Sciences Inc.

posted on Apr 01, 2009 09:22AM


CV Technologies Inc.
TSX:	CVQ

Other Recent News

April 1, 2009

COLD-FX® Maker Changes Company Name to Afexa Life Sciences Inc. as Part of Rebranding Plan

EDMONTON, ALBERTA--(Marketwire - April 1, 2009) - CV Technologies (TSX:CVQ) today announced that it is changing the Company's name to Afexa Life Sciences Inc. as part of a broader rebranding plan. The change was approved by shareholders at the Company's Annual General Meeting in Edmonton last week and takes effect today, following the filing of the Articles of Amendment. The ticker symbol under which the Company's common shares trade on the Toronto Stock Exchange (TSX) is also changing from CVQ to FXA. The Company expects that the common shares will commence trading under the new name and ticker symbol over the next two to three business days.

Company Executive Chair Jack Moffatt described the name change as a significant moment in the Company's history and signals its continuing corporate revitalization and its positioning as an influential life sciences company on the threshold of a variety of exciting opportunities.

"The name "CV Technologies" did not convey our rigorous life sciences orientation, or support our plans to leverage our market leading product as we launch new ones. Drawing on the outstanding brand equity associated with COLD-FX, we have chosen the name - Afexa Life Sciences Inc."

Mr. Moffatt added, "We expect over time to benefit from a halo effect - extending some of the popularity and goodwill associated with COLD-FX and its status as Canada's # 1 selling cold and flu remedy to new products, which are being developed through the same scientific rigour and exacting clinical trial process we applied to our core brand. Afexa (and future product names) will all phonetically echo the '-FX' tagline conveying the Science and innovation we will use to enhance our position in the wellness and self-care marketplace."

The Afexa name will begin appearing on products starting this fall as part of a larger plan to change packaging and messaging which began several months ago. In addition, a new product launch, currently planned for later this year will reflect the new packaging.

ABOUT AFEXA LIFE SCIENCES INC.

Afexa Life Sciences Inc., founded in 1992, strives to transform people's lives to be healthier and happier by focusing on prevention and recovery through the use of evidence-based naturally-derived health products. The Company's lead product COLD-FX strengths the immune system and is widely used as a leading over the counter remedy ("OTC") for helping to prevent and relieve cold and flu infections. On April 1, 2009, the Company changed its name from CV Technologies Inc. to Afexa Life Sciences Inc.

Reply New Message

Back To Forum List View

Please to post a reply